Background Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR)
have been reported to predict oncologic outcomes in patients with various types of cancer …

Cancer remains a leading causes of death worldwide and an elevated systemic
inflammatory response (SIR) is associated with reduced survival in patients with operable …

Background Explore markers to predict the clinical outcomes of checkpoint inhibitors have
high unmet needs. The following study investigates whether hematologic parameter such as …

Objective: Although there have been extensive investigations on neutrophil to lymphocyte
ratio (NLR), platelet to lymphocyte ratio (PLR) and mean platelet volume (MPV) in many …

Simple Summary Inflammation plays a major role in cancer development and progression
and has the potential to be used as a prognostic marker in cancer. Previous studies have …

Aim Rheumatoid arthritis (RA) is an inflammatory autoimmune disease with unknown
etiology and systemic involvement. Neutrophil–lymphocyte ratio (NLR) and platelet …

Objective Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have
recently been investigated as two new inflammatory markers used in the assessment of …

Background The purpose of this study was to investigate the impact of the Controlling
Nutritional Status (CONUT) score on survival compared with the platelet to lymphocyte ratio …

Objective: The aim of this study was to determine the clinical role of the systemic immune-
inflammation index in patients with resectable adenocarcinoma of the gastroesophageal …

BACKGROUND: An elevated preoperative C-reactive protein/albumin (CRP/Alb) ratio has
been reported to be associated with a poor prognosis for hepatocellular carcinoma. The aim …